Publication Date
2-1-2024
Journal
Nature Medicine
DOI
10.1038/s41591-023-02767-w
PMID
38195751
PMCID
PMC11688691
PubMedCentral® Posted Date
1-1-2025
PubMedCentral® Full Text Version
Author MSS
Published Open-Access
yes
Keywords
Humans, Receptors, Chimeric Antigen, Immunotherapy, Adoptive, Lymphoma, B-Cell, Cell- and Tissue-Based Therapy, Hematologic Neoplasms
Abstract
Reports of T cell malignancies after CAR-T cell therapy should be investigated, but existing data from follow-up studies suggest a low risk compared with other cancer treatments.
Included in
Biomedical Informatics Commons, Internal Medicine Commons, Medical Genetics Commons, Oncology Commons